Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14173060 | 0.91 | — | — | |
| SCHEMBL1494098 | 0.85 | — | — | |
| SCHEMBL14218177 | 0.83 | MAPT (0.39) | ALDH1A1TSHR | |
| SCHEMBL21042262 | 0.81 | TDP1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL14174551 | 0.79 | — | — | |
| SCHEMBL135566 | 0.78 | — | — | |
| SCHEMBL55052 | 0.72 | — | — | |
| SCHEMBL809426 | 0.69 | — | — | |
| SCHEMBL6015151 | 0.67 | MAPK1 (0.40) | TSHR | |
| SCHEMBL12174865 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105153115-B | Zwitterionic acridinium compounds | 西门子医疗保健诊断公司 | 2021-08-03 | — | — | CN | disclosed |
| EP-3067345-B1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9575062-B2 | Zwitterion-containing acridinium compounds | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-02-21 | — | — | US | disclosed |
| EP-3067345-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | Siemens Healthcare Diagnostics Inc. (US) | 2016-09-14 | — | — | EP | disclosed |
| EP-2501681-B1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2016-05-25 | — | — | EP | disclosed |
| CN-105153115-A | Zwitterion-containing acridinium compounds | SIEMENS HEALTHCARE DIAGNOSTICS | 2015-12-16 | — | — | CN | disclosed |
| CN-102762539-B | Zwitterionic acridinium compounds | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2015-07-29 | — | — | CN | disclosed |
| US-20140295575-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2014-10-02 | — | — | US | disclosed |
| US-8778624-B2 | Zwitterion-containing acridinium compounds | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2014-07-15 | — | — | US | disclosed |
| CN-102762539-A | Zwitterionic acridine compounds | SIEMENS HEALTHCARE DIAGNOSTICS | 2012-10-31 | — | — | CN | disclosed |
| EP-2501681-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | Siemens Healthcare Diagnostics Inc. (US) | 2012-09-26 | — | — | EP | disclosed |
| US-20120225497-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-09-06 | — | — | US | disclosed |
| WO-2011060228-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20070237796-A1 | Stable High Pl Hydrogel Compositions | TEXAS A&M UNIVERSITY SYSTEM, THE | 2007-10-11 | — | — | US | disclosed |
| WO-2004113432-A2 | STABLE HIGH pI HYDROGEL COMPOSITIONS | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225497-A1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | ACR, SSB, FCGR3B | ALDH1A1 2763/4885TSHR 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.